Cargando…
In Vitro and In Vivo Neuroprotective Effects of Stellettin B Through Anti-Apoptosis and the Nrf2/HO-1 Pathway
Pharmaceutical agents for halting the progression of Parkinson’s disease (PD) are lacking. The current available medications only relieve clinical symptoms and may cause severe side effects. Therefore, there is an urgent need for novel drug candidates for PD. In this study, we demonstrated the neuro...
Autores principales: | Feng, Chien-Wei, Chen, Nan-Fu, Wen, Zhi-Hong, Yang, Wen-Ya, Kuo, Hsiao-Mei, Sung, Ping-Jyun, Su, Jui-Hsin, Cheng, Shu-Yu, Chen, Wu-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627894/ https://www.ncbi.nlm.nih.gov/pubmed/31146323 http://dx.doi.org/10.3390/md17060315 |
Ejemplares similares
-
Anti-Invasion and Antiangiogenic Effects of Stellettin B through Inhibition of the Akt/Girdin Signaling Pathway and VEGF in Glioblastoma Cells
por: Cheng, Shu-Yu, et al.
Publicado: (2019) -
Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade
por: Chang, Chun-Han, et al.
Publicado: (2023) -
Stellettin B-Induced Oral Cancer Cell Death via Endoplasmic Reticulum Stress–Mitochondrial Apoptotic and Autophagic Signaling Pathway
por: Kuo, Tsu-Jen, et al.
Publicado: (2022) -
Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5
por: Chen, Yali, et al.
Publicado: (2017) -
Stellettin B Isolated from Stelletta Sp. Reduces Migration and Invasion of Hepatocellular Carcinoma Cells through Reducing Activation of the MAPKs and FAK/PI3K/AKT/mTOR Signaling Pathways
por: Tsai, Tsung-Chang, et al.
Publicado: (2022)